Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Biochem Biophys Res Commun ; 529(3): 720-725, 2020 08 27.
Article in English | MEDLINE | ID: mdl-32736698

ABSTRACT

TMEM16E deficiency has been shown to be responsible for human limb-girdle muscular dystrophy LGMD2L. We found that endogenous TMEM16E co-localized with caveolin-3 at cytoplasmic vesicular compartments in a myotube from C2C12 cells (C2C12 myotube) without forming a molecular complex. In contrast, a myotube from murine myoblastic dysferlin-deficient GREG cells (GREG myotube) showed not only co-localization but also constitutive association of caveolin-3 and TMEM16E. GREG myotubes also displayed constitutive association of TMEM16E with DHPRα, which reside in different membrane compartments, indicating increased contact of the different vesicular membrane compartments. Τhese results suggest that a dynamic tethering of different membrane compartments might represent a distorted membrane damage repairing process in the absence of dysferlin.


Subject(s)
Anoctamins/metabolism , Calcium Channels, L-Type/metabolism , Dysferlin/metabolism , Muscle Fibers, Skeletal/metabolism , Animals , Anoctamins/analysis , Calcium Channels, L-Type/analysis , Caveolin 3/analysis , Caveolin 3/metabolism , Dysferlin/analysis , Dysferlin/genetics , Gene Deletion , Male , Mice , Mice, Inbred C57BL , Muscle Fibers, Skeletal/cytology
2.
Exp Ther Med ; 12(3): 1922-1928, 2016 Sep.
Article in English | MEDLINE | ID: mdl-27588111

ABSTRACT

The records of 70 patients with oral cancer who were treated at a single institution between 2008 and 2014 were reviewed. The body temperature, white blood cell count, and C-reactive protein (CRP) levels were compared between those who had received preoperative oral care (oral care group) and those who had not received any (non-oral care group). When the patients were divided into those who underwent minimally invasive surgery and those who underwent severely invasive surgery, the mean CRP level in the early postoperative period was lower in the oral care group as compared with the non-oral care group in those who underwent minimally invasive surgery as well as those who underwent severely invasive surgery. However, the mean CRP level was most evidently reduced in the severely invasive group on days 1 and 3-5. However, no significant differences were observed with regard to the percentage of postoperative infectious complications (for example, surgical site infection, anastomotic leak and pneumonia) between the oral care (13.6%) and non-oral care (20.8%) groups, though a reduced prevalence of postoperative complications following preoperative oral care was noted. The results of the present study suggest that preoperative oral care can decrease inflammation during the early postoperative stage in patients with oral cancer who undergo severely invasive surgery.

3.
Arch Oral Biol ; 60(4): 557-65, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25601046

ABSTRACT

Bisphosphonates (BPs) are widely used in the prevention of skeletal-related events (SRE), including osteoporosis, skeletal metastases of malignant tumours, and multiple myeloma. Osteonecrosis of the jaw (ONJ) is frequently reported as a major adverse effect induced by BP treatment. The receptor activator of the nuclear factor kappa-B ligand (RANKL) inhibitor, denosumab, has recently been used to prevent SRE, but the frequency of ONJ induced by denosumab is similar to that by BPs. This finding suggests that the inhibition of RANKL-mediated osteoclastogenesis may have a close relationship with the occurrence of ONJ. We therefore investigated the expression status of RANKL-inducible genes in zoledronate-treated mouse osteoclast precursor cells. The molecular targets of zoledronate in the RANKL signal pathway and additional factors associated with osteoclastogenesis were analysed by genome-wide screening. Microarray analysis identified that among 31 genes on 44 entities of RANKL-inducible genes, the mRNA expression level of two genes, i.e., nuclear factor of activated T-cells c1 (NFATc1) and carbonic anhydrase 2 (CAII), was decreased in zoledronate-treated cells. Subsequent analyses verified that these two genes were significantly silenced by zoledronate treatment and that their expression was restored following inhibition of zoledronate action by geranylgeraniol. Zoledronate inhibited RANKL-induced osteoclast differentiation by suppression of NFATc1 and CAII gene expression. Our results suggest that these genes might be common targets for zoledronate and denosumab in the mechanism underlying RANKL-induced osteoclast differentiation. A clear understanding of the common molecular mechanisms of bone-remodelling agents is thus essential for prevention of ONJ.


Subject(s)
Carbonic Anhydrases/metabolism , Diphosphonates/toxicity , Imidazoles/toxicity , NFATC Transcription Factors/metabolism , Osteoclasts/drug effects , RANK Ligand/metabolism , Acid Phosphatase/metabolism , Animals , Carbonic Anhydrases/genetics , Cell Differentiation/drug effects , Diterpenes/pharmacology , Gene Expression , Isoenzymes/metabolism , Mice , Microarray Analysis , NFATC Transcription Factors/genetics , RNA, Messenger/metabolism , Real-Time Polymerase Chain Reaction , Signal Transduction/drug effects , Tartrate-Resistant Acid Phosphatase , Zoledronic Acid
4.
BMC Oral Health ; 14: 60, 2014 Jun 02.
Article in English | MEDLINE | ID: mdl-24889647

ABSTRACT

BACKGROUND: Onlay bone grafting techniques have some problems related to the limited volume of autogenous grafted bone and need for surgery to remove bone fixing screws. Here, we report a case of horizontal alveolar ridge atrophy following resection of a maxillary bone cyst, in which autogenous onlay bone grafting with interconnected porous hydroxyapatite ceramics (IP-CHA) and bioresorbable poly-L-lactic/polyglycolic acid (PLLA-PGA) screws was utilized. CASE PRESENTATION: A 51-year-old man had aesthetic complications related to alveolar atrophy following maxillary bone cyst extraction. We performed onlay grafting for aesthetic alveolar bone recovery using IP-CHA to provide adequate horizontal bone volume and PLLA-PGA screws for bone fixing to avoid later damage to host bone during surgical removal. During the operation, an autogenous cortical bone block was collected from the ramus mandibular and fixed to the alveolar ridge with PLLA-PGA screws, then the gap between the bone block and recipient bone was filled with a granular type of IP-CHA. Post-surgery orthopantomograph and CT scan findings showed no abnormal resorption of the grafted bone, and increased radiopacity, which indicated new bone formation in the area implanted with IP-CHA. CONCLUSION: Our results show that IP-CHA and resorbable PLLA-PGA screws are useful materials for autogenous onlay bone grafting.


Subject(s)
Absorbable Implants , Alveolar Ridge Augmentation/methods , Autografts/transplantation , Bone Screws , Bone Substitutes/therapeutic use , Bone Transplantation/methods , Durapatite/therapeutic use , Esthetics, Dental , Lactic Acid/chemistry , Maxilla/surgery , Polyglycolic Acid/chemistry , Atrophy , Denture, Partial, Fixed, Resin-Bonded , Follow-Up Studies , Humans , Incisor/surgery , Male , Maxillary Diseases/surgery , Middle Aged , Osteogenesis/physiology , Polylactic Acid-Polyglycolic Acid Copolymer , Radicular Cyst/surgery , Radiography, Panoramic/methods , Tomography, X-Ray Computed/methods
5.
J Cell Physiol ; 229(2): 181-90, 2014 Feb.
Article in English | MEDLINE | ID: mdl-23843187

ABSTRACT

TMEM16E/GDD1 has been shown to be responsible for the bone-related late-onset disease gnathodiaphyseal dysplasia (GDD), with the dominant allele (TMEM16E(gdd) ) encoding a missense mutation at Cys356. Additionally, several recessive loss-of-function alleles of TMEM16E also cause late-onset limb girdle muscular dystrophy. In this study, we found that TMEM16E was rapidly degraded via the proteasome pathway, which was rescued by inhibition of the PI3K pathway and by the chemical chaperone, sodium butyrate. Moreover, TMEM16E(gdd) exhibited lower stability than TMEM16E, but showed similar propensity to be rescued. TMEM16E did not exhibit cell surface calcium-dependent chloride channel (CaCC) activity, which was originally identified in TMEM16A and TMEM16B, due to their intracellular vesicle distribution. A putative pore-forming domain of TMEM16E, which shared 39.8% similarity in 98 amino acids with TMEM16A, disrupted CaCC activity of TMEM16A via domain swapping. However, the Thr611Cys mutation in the swapped domain, which mimicked conserved cysteine residues between TMEM16A and TMEM16B, reconstituted CaCC activity. In addition, the GDD-causing cysteine mutation made in TMEM16A drastically altered CaCC activity. Based on these findings, TMEM16E possesses distinct function other than CaCC and another protein-stabilizing machinery toward the TMEM16E and TMEM16E(gdd) proteins should be considered for the on-set regulation of their phenotypes in tissues.


Subject(s)
Chloride Channels/metabolism , Osteogenesis Imperfecta/metabolism , Alleles , Amino Acid Sequence , Anoctamin-1 , Anoctamins , Chloride Channels/chemistry , Chloride Channels/genetics , Chloride Channels/physiology , Gene Expression Regulation , HEK293 Cells , Humans , Mutation , Neoplasm Proteins/genetics , Neoplasm Proteins/metabolism , Protein Stability , Protein Structure, Tertiary
SELECTION OF CITATIONS
SEARCH DETAIL
...